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ABSTRACT 
 
BACKGROUND: 
Preclinical studies report that higher plasma viscosity improves microcirculatory flow after 
haemorrhagic shock and resuscitation, but no clinical study has tested this hypothesis.  
 
OBJECTIVE: 
We investigated the relationship between plasma viscosity and sublingual microcirculatory 
flow in patients during resuscitation for traumatic haemorrhagic shock (THS).  
 
METHODS: 
Sublingual video-microscopy was performed for 20 trauma patients with THS as soon as 
feasible in hospital, and then at 24h and 48h. Values were obtained for total vessel density, 
perfused vessel density, proportion of perfused vessels, microcirculatory flow index (MFI), 
microcirculatory heterogeneity index (MHI), and Point of Care Microcirculation (POEM) 
scores. Plasma viscosity was measured using a Wells-Brookfield cone and plate micro-
viscometer. Logistic regression analyses examined relationships between microcirculatory 
parameters and plasma viscosity, adjusting for covariates (systolic blood pressure, heart rate, 
haematocrit, rate and volume of fluids, and rate of noradrenaline).  
 
RESULTS: 
Higher plasma viscosity was not associated with improved microcirculatory parameters. 
Instead, there were weakly significant associations between higher plasma viscosity and 
lower (poorer) MFI (p=0.040), higher (worse) MHI (p=0.033), and lower (worse) POEM 
scores (p=0.039). 
  
3 
 
CONCLUSIONS:  
The current study did not confirm the hypothesis that higher plasma viscosity improves 
microcirculatory flow dynamics in patients with THS. Further clinical investigations are 
warranted to determine whether viscosity is a physical parameter of importance during 
resuscitation of these patients.  
 
Key words 
Viscosity; microcirculation; haemorrhage; trauma; fluids 
 
 
 
 
1. INTRODUCTION 
 
Following traumatic haemorrhagic shock, strategies for resuscitation are usually guided by 
circulatory parameters such as mean arterial pressure and cardiac output, and biochemical 
markers of perfusion, such as lactate, base deficit, and oxygen partial pressures. Although 
these parameters are surrogate markers for tissue perfusion, the true physiological association 
between the macro- and microcirculation may be disrupted during periods of loss of 
haemodynamic coherence[1, 2], when conventional parameters may not adequately reflect 
the state of the microcirculation. There has been recent clinical evidence that 
microcirculatory flow is superior to macrocirculatory parameters in predicting subsequent 
organ failure after traumatic haemorrhagic shock[3], and a number of studies have 
investigated the relationship between the microcirculation and clinical outcomes following 
shock[4]. The importance of the microcirculation in the management of shock has prompted 
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some investigators to propose direct microcirculatory monitoring as one strategy for 
assessing status of critically unwell patients[5-8].  
 
There have not yet been any clinical investigations of the effects of resuscitation fluids on 
microcirculatory flow following haemorrhagic shock, although there have been many 
preclinical (animal) studies[9]. Evidence from preclinical studies suggests that the physical 
(rheological and osmotic) properties of resuscitation fluids may be as important as their 
constituents in the restoration of microcirculatory flow[9, 10]. In particular, some 
investigators have shown that higher plasma viscosity may improve microcirculatory flow in 
small animal models of haemodilution[11] and haemorrhagic shock[12-15]. Since these 
findings were not confirmed by larger animal models[16, 17], there is some uncertainty about 
which evidence might be translatable to patients. A large study of healthy human volunteers 
reported that higher plasma viscosity was associated with better capillary flow during post-
ischaemic hyperaemia [18]. A clinical investigation of the influence of plasma viscosity on 
microcirculatory flow dynamics following shock is warranted, since this may impact on the 
optimum choice of fluid for resuscitation.  
 
Barras originally proposed that plasma viscosity may be the main influencing parameter on 
capillary flow, because blood viscosity approaches plasma viscosity in these micro-vessels 
[19]. The magnitude of blood viscosity depends in a non-linear fashion on the haematocrit 
(volume fraction of red blood cells), and is proportional to the suspending phase, plasma 
viscosity[20-22]. The apparent viscosity of the blood decreases markedly in micro-vessels 
with diameter <100µm due to the Fahraeus effect, whereby haematocrit decreases from the 
systemic values due to phase separation and central flow of the red cells; a minimum 
viscosity occurs in capillaries with diameter ~7µm where the red cells are aligned in a single 
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column[23]. However, plasma viscosity continues to influence flow resistance regardless of 
haematocrit, and changes in this factor will affect perfusion at all levels of the vascular tree. 
Indeed, within the microcirculation, the plasma viscosity may be particularly influential given 
the reduction in local haematocrit, as described by Barras [19]. During periods of 
physiological compromise such as haemorrhagic shock, changes in overall blood viscosity 
may directly influence microcirculatory perfusion due to loss of autoregulation[24]. Thus, 
alterations in haematocrit and plasma viscosity that influence blood viscosity are expected to 
influence tissue perfusion, and may be important determinants of microcirculatory flow after 
traumatic haemorrhagic shock. However, this possibility has not yet been investigated in 
human subjects.   
 
We sought to investigate the relationship between sublingual microcirculatory flow dynamics 
and plasma viscosity in a cohort of patients with traumatic haemorrhagic shock. We 
hypothesised that higher plasma viscosity would improve microcirculatory flow in keeping 
with evidence from preclinical studies [9] and healthy subjects [18].  
 
 
2. METHODS 
2.1. Study design 
The current study is a subgroup analysis of 20 patients from a single site (University 
Hospitals Birmingham NHS Foundation Trust) within the MICROSHOCK study, a 
longitudinal prospective observational investigation of patients with traumatic haemorrhagic 
shock (Registration ID: NCT02111109) [25, 26]. This study was approved by a UK Research 
Ethics Committee (Ref: 14/YH/0078) prior to patient enrolment.   
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2.2. Patient enrolment 
Patients were eligible for inclusion in the MICROSHOCK study if they had been injured, 
required blood products, had a serum lactate 2mmol/l, were intubated, and required 
admission to the Intensive Care Unit (ICU). Patients under the age of 18 and those with 
injuries incompatible with survival were excluded. Patients were unable to consent for 
themselves due to lack of capacity, and therefore their participation was guided by the Mental 
Health Capacity Act 2005, the Declaration of Helsinki, and the principals of Good Clinical 
Research Practice. The doctor in charge of the clinical care of the patient gave permission for 
study participation. A close friend or relative was also approached to assent to ongoing study 
participation according to their perceptions of the patient’s wishes. Ultimately if the patient 
re-gained capacity, their informed consent was sought in order to retain all data previously 
recorded.   
 Patients were enrolled in the study as early as possible, preferably in the Emergency 
Department, or on admission to ICU. This time point was designated as Time Point 1. Data 
were collected at a further two time points: Time point 2 (24h later), and Time Point 3 (48h 
after Time Point 1).   
 
2.3. Imaging of the microcirculation 
Sublingual video-microscopy was performed to obtain video clips of the microcirculation 
using an Incident Dark Field (IDF) video-microscope (Cytocam, Braedius Medical B.V., 
Huizen, The Netherlands). The video-microscope was placed gently under the tongue of 
patients and aimed towards the sublingual mucosa until a clear image was obtained on the 
video monitor. Care was taken to only view sublingual microcirculation (rather than the 
characteristic looped tongue vessels), and to minimise artefacts (including saliva and 
sediment), optimise the illumination and focus, and minimise movement and pressure 
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artefacts, in order to achieve the highest quality video clips for analysis[27]. At least 3, and 
preferably 5 separate clips from different areas of the sublingual mucosa were recorded 
according to consensus guidelines[28]. These clips were stored on an encrypted device and 
saved for analysis en masse.   
 
2.4. Analysis of microcirculatory flow dynamics 
All recorded video clips were analysed offline, away from the patient bedside. Each clip was 
assigned a random number so that they were analysed without the user knowing the patient or 
time point. Firstly, each clip was scored according to the 6 factors recommended for quality 
assessment (anatomy, focus, illumination, duration, stability, and pressure artefact)[27]. At 
least 3, and up to 5 of the clips that were of highest quality were analysed using Automated 
Vascular Analysis V.3.02 (Microvision Medical, The Netherlands). During analysis of each 
clip, all vessels 20m were individually traced, and the computer software calculated the 
Total Vessel Density (TVD, mm/mm2) of micro-vessels from these tracings. Each vessel 
segment was then assigned a flow score from 0–3 (none=0, intermittent=1, sluggish=2, and 
normal=3), from which the Perfused Vessel Density (PVD, mm/mm2) was derived, according 
to the density of vessels that have a flow score of 2. The Proportion of Perfused Vessels 
(PPV, %) is derived from the proportion of vessels that have a flow score of 2. A flow score 
was also given for each quadrant, with the Microcirculatory Flow Index (MFI) derived from 
their average value, according to the Boerma method[29]. The Heterogeneity Index (HI) was 
calculated as the highest minus the lowest flow score, divided by the MFI. Together, the 
TVD, PVD, PPV, MFI, and HI form the “ideal analysis report” of the microcirculation, 
according to consensus opinion[28]. A further composite score for flow and heterogeneity 
(the Point of Care Microcirculation (POEM) score) was assigned to videos clips according to 
recently published algorithm[8]. In brief, each of 4 videos from the same patient time point 
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were graded for flow, as “normal”, “impaired”, or “critical”, corresponding to <25%, >25%, 
and >50% of vessel segments with sluggish or stopped flow. Clips with “normal” flow were 
then attributed with heterogeneity if >5 vessel segments were different to the remainder, or 
no heterogeneity. An overall score for all 4 clips was then assigned on an ordinal scale from 1 
to 5 according to an algorithm[8]. For TVD, PVD, PPV, MFI, and POEM scores, higher 
values indicate better microcirculatory function, whereas for MHI a higher value is indicative 
of poorer microcirculatory function.  
 
2.5. Blood sampling 
12ml of peripheral blood was sampled from patients at the same time as video-microscopy, 
using BD Vacutainers® (Becton Dickinson, Oxford, UK) containing citrate for anti-
coagulation (to measure the plasma viscosity) and EDTA (to measure haematocrit). The 
citrate tubes were taken straight to the laboratory and prepared in order to obtain platelet-free 
plasma. This was done by centrifuging the samples at 2000 x g for 20 minutes; then the upper 
2/3rd of the samples were extracted and centrifuged for a second time, at 13,000 x g for 2 
minutes. On both occasions this was done at 4oC. The resulting samples were stored at -80°C 
until they were analysed. Care was taken to prepare all samples in an identical manner. The 
EDTA tube was run through the Sysmex XN-1000 analyser (Sysmex UK, Milton Keynes, 
UK) to determine the haematocrit.   
 
2.6. Measurement of plasma viscosity 
Plasma viscosity was determined using a Wells-Brookfield cone and plate micro-viscometer 
(AMETEK GB Ltd, Harlow, UK). All samples were run at 21oC. A 1ml sample was added to 
the plate, and the cone was rotated to provide a shear rate of 230s-1 and maximum detectable 
viscosity of 10mPa·s. The instrument was validated before and after samples using distilled 
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water, which yielded a viscosity of 1mPa·s (in keeping with the expected viscosity of water 
of 0.98 mPa·s at 21oC [30]). All samples were run three times, and an average value 
obtained. The cone and plate were cleaned after every sample in order to eliminate residual 
protein deposits on the instrument.  
 
2.7. Clinical data 
This non-interventional study did not influence the fluid or inotropic delivery. Observational 
data were obtained regarding physiological parameters at the same time as the 
microcirculatory readings, including systolic blood pressure (SBP), heart rate (HR). 
Furthermore, the rates of noradrenaline and fluid delivery were recorded at the study time 
points, as well as the total volumes of fluids and crystalloids delivered since the previous 
time point (or since injury for the first time point). Data regarding patient characteristics on 
admission to hospital included age, gender, weight, injury severity score (ISS), APACHE-2, 
Glasgow Coma Scale (GCS), and lactate 
 
2.8. Endothelial biomarkers and viscosity 
A subgroup analysis was planned for the patients from the same cohort who have had 
biomarkers of endotheliopathy (syndecan-1 and thrombomodulin) reported in a previous 
study (n=17) [31]. For these patients, viscosity was compared to biomarker levels for these 
patients at each time point in order to determine whether endotheliopathy of trauma was 
associated with differences in viscosity.  
 
2.9. Data analysis 
The current study investigated the relationship between 6 microcirculatory flow dynamics 
parameters (TVD, PVD, PPV, MFI, POEM, and HI) and plasma viscosity, as well as each of 
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their relationships with time, using logistic regression analysis. For each microcirculatory 
parameter that had a statistically significant relationship to viscosity, a series of logistic 
analyses were performed in order to identify any modifying effects of 7 pre-specified 
covariates (SBP, HR, haematocrit, rate of noradrenaline, rate of fluids, total volume of fluids, 
and total volume of crystalloids). Spearman’s correlation co-efficient was used to determine 
univariate correlations, and reported as r and 95% confidence intervals (CI). A Kruskal-
Wallis test was used to compare multiple groups of non-normal continuous variables. A p-
value of < 0.05 was considered statistically significant.  
 
3. RESULTS 
3.1. Patient characteristics 
There were 20 patients, of which 19 were male. The characteristics of all study patients are 
illustrated in Table 1. Because these characteristics were potentially confounding variables, 
they were compared to plasma viscosity at the first time point, and there were no significant 
correlations. When these characteristics were compared to the 6 microcirculatory parameters, 
there was a correlation between age and both PPV (r = -0.586 (95% CI -0.845– -0.105); 
p<0.05) and HI (r = 0.604 (95% CI 0.133–0.853); p<0.05) (Table 2).  
 
3.2. Fluid resuscitation 
All patients received crystalloid fluids during the study period, with a median volume of 2000 
(IQR 0–3000) ml in between time points, and a median rate of fluid delivery of 1.7 (0–2.1) 
ml/min. Only 5 patients received colloid fluids at any time during the study period (median 
volume 1000 (IQR 0–2000) ml. When the rate of fluid delivery was compared to plasma 
viscosity, there were no significant correlations at the first (r = -0.232; p=0.401) (Fig 1a), 
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second (r = 0.202; p = 0.449) (Fig 1c), or third (r = -0.372; p = 0.172) (Fig 1e) time points. 
When the volume of fluids delivered were compared to plasma viscosity, there was a 
significant correlation at the first time point (r = -0.734; p = 0.0025) (Fig 1b), but not at the 
second (r = 0.394; p = 0.131) (Fig 1d), or third (r = -0.272; p = 0.323) (Fig 1f) time points. 
 
3.3. Viscosity  
The median plasma viscosity for all samples was 2.1 (IQR 1.9–2.7) mPa·s. There were no 
significant differences between time points, with the median values for viscosity at the three 
time points being 2.1 (IQR 1.9–3.1) mPa·s, 2.1 (IQR 2.0–2.6) mPa·s, and 1.9 (1.8–2.3) 
mPa·s respectively; p=0.597.  
 
3.4. Plasma viscosity and microcirculatory flow dynamics 
Higher plasma viscosity was not associated with improved microcirculatory flow or 
heterogeneity. Instead, there were weakly significant associations between higher plasma 
viscosity and lower (poorer) MFI (p=0.040) (Fig 2a), higher (worse) MHI (p=0.033) (Fig 2b), 
and lower (worse) POEM scores (p=0.039) (Fig 2c). MFI, MHI, and POEM scores all 
improved over the three time points (p=0.001) (Fig 2). When covariates were examined, there 
were no statistically significant relationships between any of haematocrit, rate of fluids, rate 
of noradrenaline, total volume of fluids, or total volume of crystalloids with MFI, MHI or 
POEM scores in models that included plasma viscosity and time. However, there were 
significant relationships between MFI and both SBP (p=0.033) and HR (p=0.047); between 
MHI and SBP (p=0.041); and between POEM score and both SBP (p=0.003) and HR 
(p=0.020). After adjusting for these covariates, the weakly significant relationships were 
unchanged between plasma viscosity and MFI (p=0.038), MHI (p=0.037), and POEM scores 
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(p=0.044). There were no significant associations between plasma viscosity and TVD 
(p=0.242), PVD (p=0.806), or PPV (p=0.064) (Fig 3). 
 
3.5. Viscosity and endotheliolopathy 
When viscosity was compared to levels of syndecan-1, there were no statistically significant 
correlations at the first (r=0.409; p=0.187), second (r=-0.349; p=0.243), or third (r=-0.305; 
p=0.288) time points. There were no statistically significant correlations between viscosity 
and thrombomodulin at the first (r=0.123; p=0.703) or third (r=-0.093; p=0.751) time points. 
However, there was a significant negative correlation between thrombomodulin and viscosity 
at the second time point (r=-0.660; p=0.014).  
 
4. DISCUSSION 
In this non-interventional study of 20 patients with traumatic haemorrhagic shock, we could 
not confirm an association between higher plasma viscosity and improved microcirculatory 
flow dynamics. Indeed, for some of the microcirculatory parameters there was a weak 
correlation with plasma viscosity in the opposite direction to expected. Furthermore, there 
were no associations between biomarkers of endothelial disruption and plasma viscosity. 
Lower plasma viscosity appeared to be associated with higher fluid volumes at the first time 
point, but not subsequently, and the rate of fluid delivery did not seem to affect plasma 
viscosity. These findings are in direct contrast to the data reported from experimental studies 
that utilised small animal models of haemorrhagic shock, which have reported beneficial 
effects of raising the plasma viscosity on subsequent microcirculatory flow [14, 32-34]. To 
our knowledge, this is the first study to investigate the relationship between plasma viscosity 
and microcirculatory flow in human subjects after trauma and haemorrhagic shock.  
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Viscosity has been proposed as a physical component of interest when choosing the “ideal 
fluid” to restore the microcirculation during resuscitation from haemorrhagic shock[9]. 
Preclinical studies have investigated the effects on the microcirculation of fluids designed to 
be of higher viscosity than conventional crystalloids, such as preparations of hydroxyethyl 
starch[13, 35], pegylated albumin[36], and the addition of alginate to other preparations[32, 
33]. One of the main principles of their design is to deliver a fluid that might be able to 
restore and sustain tissue perfusion in the microcirculation through adequate plasma 
expansion, whilst only delivering a small volume and not causing fluid overload[33]. It has 
been proposed that higher viscosity preparations might remain in the intravascular space for 
longer, with longer lasting effects on volume and microcirculatory flow[13]. Indeed, some 
investigators have proposed that there are circumstances where the viscosity properties of red 
blood cells (RBCs) that are of more importance to the microcirculation than their actual 
oxygen-carrying capacity[37], and that oxygen extraction ratio in tissues might be improved 
by increasing the overall viscosity rather than number of RBCs[36]. Data from these 
experimental studies imply that an environment of higher blood viscosity is desirable for the 
microcirculation after haemorrhagic shock, and may be a potential strategy for fluid 
resuscitation. If these findings were applicable to humans, then fluids with higher viscosity 
would be desirable for low volume resuscitation of patients.  
 
The current study findings are in keeping with those of large animal models that found no 
effects of plasma viscosity on microcirculatory flow in a canine model[17], and no difference 
in microcirculatory flow between high and low viscosity fluids in a swine model[16]. It is 
noteworthy however, that in the latter of these studies, the higher viscosity fluid required a 
lower volume to achieve the same plasma viscosity and microcirculatory endpoints than the 
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lower viscosity fluid. Such a finding would suggest that higher viscosity fluids might be 
favourable for low volume resuscitation. Indeed, delivery of a lower volume resuscitation 
fluid with higher viscosity has been recommended for combat casualties in order to facilitate 
permissive hypotension[38]. In the current study, the rate of fluid delivery did not appear to 
influence the plasma viscosity, and the volume of fluids delivered was only correlated with 
plasma viscosity at the first time point. The majority of fluid given to patients in this study 
cohort was crystalloid (0.9% saline or Hartmann’s solution), with only 5 receiving any type 
of colloid at any time during the study period, and therefore no meaningful comparison could 
be made between different fluid types. Further investigations are required to compared types 
of fluid, their effects on viscosity, microcirculatory flow, and clinical outcomes amongst 
patients after haemorrhagic shock.  
 
Previous small animal models of haemorrhagic shock and fluid resuscitation are more in 
keeping with the physical laws of flow with regards to viscosity in micro-vessels, with the 
majority of studies using intra-vital microscopy reporting superior flow with higher plasma 
viscosity[9]. It is likely that under these well controlled conditions, with individually isolated 
vessels and precise techniques, that flow is more likely to follow the expected physical laws 
than within the heterogenous sublingual microcirculation of critically unwell human subjects. 
In the clinical setting there are likely to be many confounding factors that affect the precision 
of video-microscopy, and make it more difficult to confirm hypotheses generated from these 
preclinical studies. This may account for the findings in the current study. Nevertheless, the 
implications of this discrepancy between patients and animal models may be significant when 
considering the translatability of preclinical studies, and whether the viscosity of resuscitation 
fluids is indeed a factor of relevance in clinical practice.  
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Patients in the current study had suffered traumatic injury as well as haemorrhagic shock, and 
it is likely that these conditions are more complex than those of preclinical studies of 
haemorrhagic shock alone. Injury is associated with a complex array of early pathological 
processes such as endotheliopathy[39], coagulopathy[40], and inflammatory 
dysregulation[41], all of which have the potential to influence viscosity due to changes in 
circulating molecules and their interaction with the vascular endothelium. The current study 
did not find consistently significant relationships between biomarkers of endotheliopathy and 
viscosity in either direction, but a detailed analysis of circulating molecules and viscosity is 
warranted in a larger cohort of trauma patients. Since haemorrhagic shock is most likely to 
occur following injury in patients (rather than in isolation), future preclinical investigations of 
viscosity and microcirculatory flow may have improved translatability if a mode of injury is 
incorporated into their protocols.  
 
4.1. Limitations 
The current study has a low number of patients, with all of the statistical implications 
associated with this. Since no other studies were found that investigated the same research 
question in humans, a power calculation could not be undertaken. Further investigations are 
warranted based on our preliminary findings. The patient cohort was heterogeneous, with a 
wide range in injury types and burden, and treatments. It is possible that there may be 
different relationships between plasma viscosity and microcirculatory flow in some 
subgroups and not others, but this could not be determined within the current study. It is 
acknowledged that guidelines for rheological measurements recommend non-diluent 
anticoagulants such as heparin [42]. However, our protocol utilised blood collection tubes 
containing citrate because this was required for additional investigations other than those 
rheological measurements described here.  
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4.2. Conclusions 
In this observational study of patients with traumatic haemorrhagic shock, we did not observe 
any improvement in microcirculatory flow in the presence of higher plasma viscosity. Indeed, 
there was some unexpected evidence of superior microcirculatory flow and heterogeneity 
with lower plasma viscosity. Since these findings are not in keeping with the hypotheses 
generated from preclinical studies, further clinical investigations are warranted to determine 
whether a higher plasma viscosity is desirable for patients following traumatic haemorrhagic 
shock, and whether viscosity is a physical component of importance in the choice of 
resuscitation fluid for these patients.  
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Table 1.  Study patient characteristics, with all continuous variables compared to 
plasma viscosity at the first time point 
 
  
Correlation with plasma viscosity 
Characteristics 
Average for all patients,  
median (IQR) r (95% CI) p-value 
Demographic and injury 
   
       Age, years 37 (26 – 51) 0.105 (-0.430 – 0.586) 0.710 
       Weight, kg 85 (70 – 93) -0.438 (-0.776 – 0.096) 0.103 
       ISS 26 (17 – 34) 0.015 (-0.502 – 0.523) 0.959 
Physiological parameters in ED 
   
       APACHE-2 10 (8 – 14) -0.125 (-0.652 – 0.484) 0.700 
       SBP, mmHg 92 (64 – 108) 0.036 (-0.486 – 0.538) 0.900 
       HR, min-1 112 (99 – 127) 0.268 (-0.283 – 0.686) 0.335 
       Lactate, mmol/l 5.9 (3.5 – 10.8)  -0.247 (-0.674 – 0.304) 0.376 
       Pre-intubation GCS 8 (3 – 12) 0.011 (-0.504 – 0.520) 0.969 
IQR: interquartile rage; ISS: injury severity score; SBP: systolic blood pressure; HR: heart rate; GCS: 
Glasgow Coma Score; CI: confidence interval 
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Table 2.  Comparison between potential confounding patient characteristics and all 
microcirculatory parameters at the first time point 
 
 
p-values for univariate correlation with microcirculatory 
parameters: 
Characteristics TVD PVD PPV MFI HI POEM 
Demographic and injury 
 
     
       Age, years 0.574 0.075 0.022* 0.071 0.017* 0.086 
       Weight, kg 0.124 0.494 0.090 0.317 0.716 0.530 
       ISS 0.522 0.806 0.958 0.608 0.942 0.538 
Physiological parameters in ED 
 
     
       APACHE-2 0.496 0.250 0.469 0.711 0.597 0.840 
       SBP, mmHg 0.811 0.593 0.628 0.374 0.424 0.386 
       HR, min-1 0.337 0.289 0.471 0.342 0.305 0.152 
       Lactate, mmol/l 0.358 0.772 0.932 0.528 0.554 0.703 
       Pre-intubation GCS 0.094 0.115 0.389 0.657 0.691 0.971 
*significant using Spearman’s correlation coefficient 
IQR: interquartile rage; ISS: injury severity score; SBP: systolic blood pressure; HR: heart rate; GCS: 
Glasgow Coma Score; CI: confidence interval 
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FIGURE CAPTIONS 
 
Fig 1. Plasma viscosity according to rate of fluid delivery and volume of fluid at the first 
(A and B), second (C and D), and third (E and F) time points. Panel B shows the 
correlation between volume of fluid and viscosity, with interrupted lines indicating 95% 
confidence intervals.   
 
Fig 2. Relationship between plasma viscosity and (a) microcirculatory flow index (MFI); 
(b) microcirculatory heterogeneity index (MHI); and (c) Point of Care Microcirculation 
(POEM) score at three time points. The shaded areas indicate the 95% confidence 
intervals.  
 
Fig 3. Relationship between plasma viscosity and (a) total vessel density (TVD); (b) 
perfused vessel density (PVD); and (c) proportion of perfused vessels (PPV) at three 
time points. The shaded areas indicate the 95% confidence intervals.  
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Fig 1. Plasma viscosity according to rate of fluid delivery and volume of fluid at the first 
(A and B), second (C and D), and third (E and F) time points. Panel B shows the 
correlation between volume of fluid and viscosity, with interrupted lines indicating 95% 
confidence intervals.   
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Fig 2. Relationship between plasma viscosity and (a) microcirculatory flow index (MFI); 
(b) microcirculatory heterogeneity index (MHI); and (c) Point of Care Microcirculation 
(POEM) score at three time points. The shaded areas indicate the 95% confidence 
intervals.  
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Fig 3. Relationship between plasma viscosity and (a) total vessel density (TVD); (b) 
perfused vessel density (PVD); and (c) proportion of perfused vessels (PPV) at three 
time points. The shaded areas indicate the 95% confidence intervals.  
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